A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

Table 1 Description of baseline patient characteristics

Characteristics	Number
Gender
Females	25 (61%)
Males	16 (39%)
Median age (range)	27 (14–58 years)
Smokers (current/ex-smoker)	14 (34%)
Pathology
Nodular Sclerosing	39 (95%)
Nodular Lymphocyte Predominant	1 (2%)
Mixed Cellularity	1 (2%)
Stage I	4 (10%)
II	34 (85%)
III	2 (4%)
N/A (Relapse)	1 (2%)
Bulky disease *	28 (72%)
Chemotherapy Regimen
ABVD	38 (93%)
Other	3 (7%)
Median cycles (range)	4 (3–8)
35 Gy IFRT plan – Treatment Indication
Adjuvant	37
Post Transplant	3
Adjuvant Post-Relapse	1

* Bulky disease was defined as ≥ 5 cm on CT scan, and/or a thoracic ratio of maximum transverse mass diameter ≥ 33% of the internal transverse thoracic diameter measured at the T5/6 intervertebral disc level on chest radiography.

ISSN: 1748-717X